pd 145065 has been researched along with thromboxanes in 1 studies
| Studies (pd 145065) | Trials (pd 145065) | Recent Studies (post-2010) (pd 145065) | Studies (thromboxanes) | Trials (thromboxanes) | Recent Studies (post-2010) (thromboxanes) |
|---|---|---|---|---|---|
| 76 | 1 | 5 | 3,202 | 149 | 199 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cittadino, MH; Gordo, WM; Moreno, H; Tanus-Santos, JE; Udelsmann, A | 1 |
1 other study(ies) available for pd 145065 and thromboxanes
| Article | Year |
|---|---|
Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs.
Topics: Animals; Dogs; Embolism, Air; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemodynamics; Male; Oligopeptides; Prospective Studies; Pulmonary Embolism; Thromboxanes | 2000 |